Published in
Public Library of Science, PLoS Medicine, 2(13), p. e1001964, 2016
DOI: 10.1371/journal.pmed.1001964
Links
- ORCID
- Public Library of Science
- ORCID
- ORCID
- ORCID
- ORCID
- [ihi.eprints.org] | PDF
- [diposit.ub.edu] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study
Journal article published in 2016 by
María Rupérez,
Smaï la Ouédraogo,
Rella Manego Zoleko,
Raquel González,
Ghyslain Mombo-Ngoma,
Abdunoor M. Kabanywanyi,
Esperança Sevene 
,
Smaïla Ouédraogo,
Mwaka A. Kakolwa,
Anifa Vala,
Manfred Accrombessi,
Valérie Briand ,
John J. Aponte,
Rella Manego Zoleko,
Ayôla A. Adegnika
and other authors.
,
Smaïla Ouédraogo,
Mwaka A. Kakolwa,
Anifa Vala,
Manfred Accrombessi,
Valérie Briand ,
John J. Aponte,
Rella Manego Zoleko,
Ayôla A. Adegnika
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Little is known about the effects of intermittent preventive treatment of malaria in pregnancy (IPTp) on the health of sub-Saharan African infants. We have evaluated the safety of IPTp with mefloquine (MQ) compared to sulfadoxine-pyrimethamine (SP) for important infant health and developmental outcomes.